Smith & Nephew, Advanced Tissue Sciences announce Dermagraft receives CMS pass-through code.
Smith & Nephew pic, Largo, FL and Advanced Tissue Sciences, La Jolla, CA announced that Dermagraft Human Fibroblast-Derived Skin Substitute has received an Ambulatory payment Classification (APC (1) (American Power Conversion Corporation, West Kingston, RI, www.apcc.com) The leading manufacturer of UPS systems and surge suppressors, founded in 1981 by Rodger Dowdell, Neil Rasmussen and Emanual Landsman, three electronic power engineers who had worked at MIT. ) pass-through code under the Hospital Outpatient Prospective Payment System from the Centers for Medicare & Medicaid Services (CMS (1) See content management system and color management system.
(2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. - formerly HCFA HCFA
Health Care Financing Administration
n.pr See Health Care Financing Administration. ).
The companies say the pass-through payment code for Dermagraft (C 9201) covers Medicare patients with diabetic foot ulcers treated in a hospital out-patient setting. It will be effective January 1, 2002. The FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. cleared the PMA for Dermagraft in the treatment of foot ulcers for diabetics on September 28. Dermagraft is the first human-based cryopreserved, living dermal substitute approved by the lFDA.
Contact: Advanced Tissue Sciences - (619) 450-5730